Advantage Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Advantage Investment Management's AMGN Position: Q3 2019 in Review
Advantage Investment Management increased its Amgen (AMGN) stake by 1.3% in Q3 2019, buying an estimated $3.26K and bringing the position to 1,343 shares worth $260K. The position accounts for 0.2% of the portfolio, ranked #93.
Advantage Investment Management first reported a position in AMGN in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.35M in Q4 2015. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.
- Advantage Investment Management held 1,343 shares of Amgen worth $260K as of Q3 2019.
- Advantage Investment Management bought 17 Amgen shares in Q3 2019, an estimated $3.26K.
- Amgen made up 0.2% of Advantage Investment Management's portfolio in Q3 2019, its #93 holding.
- Advantage Investment Management first reported a position in Amgen in Q4 2014 and has held it in 20 quarters since.
- Advantage Investment Management's Amgen position peaked at $2.35M in Q4 2015.
- 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.
Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.